Study compares postoperative refractive accuracy of formula-modified keratometry values versus total keratometry values obtained by a swept-source OCT biometer with new-generation multivariable IOL calculation formulasMay 4th 2022
Older generation non-LVC formulas show marked improvement upon using TK values vs K, while multivariable non-LVC formulas did not consistently improve.
Study: IOL calculation remains challenging in PKP eyesMay 4th 2022
The study assesses and compares the accuracy of IOL formulas using keratometry (K) and total keratometry (TK) values obtained by a swept-source OCT biometer (IOL Master 700) in eyes with previous PKP prior to cataract surgery.
Retrospective cohort study looks at adverse intraoperative and postoperative events following cataract surgery for patients with prior intravitreal injections and incisional retinal proceduresMay 3rd 2022
The project, presented by Colton Hill, MPH, on behalf of the Dean McGee Eye Institute, looks at complication rates during cataract surgery or after cataract surgery for patients with prior intravitreal injections or incisional retinal procedures.
Taping surgical masks to the skin decreases risk of ocular surface damage during the COVID-19 pandemicMay 2nd 2022
During a presentation at the Association for Research in Vision and Ophthalmology’s 2022 annual meeting in Denver, Yuichi Hori, MD, PhD, and colleagues found that taping the top border of a surgical mask to a clinicians’ skin reduces the potential for ocular surface damage resulting from expirations of air reaching the ocular surface during the COVID-19 pandemic.
Blog: TAGS trial and real life applicationsMay 2nd 2022
Joseph Panarelli, MD, and Arsham Sheybani, MD, discuss the Primary Trabeculectomy for Advanced Glaucoma: Pragmatic Multicentre Randomized Controlled Trial, or TAGS trial, and how this can apply to real world situation. This multicenter randomized controlled trial evaluated whether primary trabeculectomy or primary medical treatment leads to improved outcomes in terms of quality of life, clinical effectiveness, and safety.
Riad Sherif, CEO of Oculis, gives a company update on clinical trials, financing and other items in the pipelineApril 29th 2022
Riad Sherif, MD, CEO of Oculis, gives a company update on clinical trials for products in DME, ocular surgery, and more; plus, growing products in glaucoma treatments, team and financing updates.
Study: Surgeon and anesthesiologist satisfaction an unreliable indicator of patient satisfaction during ocular surgeryApril 29th 2022
According to Boston Medical Center investigators, providers and patients often disagree on what defines adequate sedation and comfort during surgery.
The glaucoma market: Novel devices, drugs drive rapid, sustained expansionApril 26th 2022
The glaucoma market seems to be in an expansion phase, as evidenced by the explosions in the number of new pharmaceutical and surgical options entering the marketplace. The introduction of new devices is possibly the single most influential factor currently driving the glaucoma market.
CSF-1 Phase 2B clinical trials for presbyopia met primary and secondary endpointsApril 25th 2022
In a presentation at the American Society of Cataract and Refractive Surgery’s 2022 annual meeting, Marjan Farid, MD, ABO, and Preeya K. Gupta, MD, offered details of clinical trials for CSF-1 ophthalmic solution, a presbyopia eye drop candidate. Results showed that nearly half of the participants treated with CSF-1 achieved a 3-line or more increase in the distance-corrected near visual acuity an hour after drop instillation on day 15.
Patients with higher preoperative measurements of angle kappa and angle alpha may experience blurry vision, dry eyes following cataract surgeryApril 25th 2022
Anushka M. Raj, BS, second year medical student at the University of Oklahoma’s Dean McGee Eye Institute, presents "Inter-Device Measurement Reliability of Angle Kappa and Angle Alpha, Devices and Instruments" during ASCRS.
Effects of diabetic retinopathy on early visual outcomes after cataract surgeryApril 24th 2022
According to an e-poster presented by Jagadesh C. Reddy, MD, and Harini Indusekar, BScOptom, at the American Society of Cataract and Refractive Surgery’s 2022 annual meeting in Washington, D.C., patients who have pre-existing DR are less likely to achieve Snellen 20/40 or better vison after cataract surgery compared with the patients with diabetes but without DR.
Combination eye drop manages inflammation and infection after cataract surgeryApril 23rd 2022
Blake K. Williamson, MD, MPH, MS, and coauthor Urvi Patel, BSc, presented an e-poster at the American Society of Cataract and Refractive Surgery’s 2022 annual meeting in Washington, D.C., on the efficacy of a combination eye drop comprised of an antibiotic, anti-inflammatory and lubricant as part of a postoperative treatment regimen following cataract surgery.
Emerging medical and surgical presbyopic treatmentsApril 18th 2022
Ophthalmologists have several options at their disposal for the treatment of presbyopia, according to Elizabeth Yeu, MD, a partner at Virginia Eye Consultants and an assistant professor at Eastern Virginia Med¬ical School in Norfolk. Speaking recently at the virtual 2022 Toronto Cataract Course, Yeu noted that innovation is advancing in presbyopia correction.
Alcon introduces VR surgical training technologyApril 12th 2022
This advancement reinforces Alcon’s commitment to surgeon training and education, as part of the Alcon Experience Academy. The new device will be introduced at the upcoming ASCRS meeting and surgeons will be able to experience the new technology firsthand.
VJCRGS issue celebrates ‘great lectures’ in ophthalmologyApril 11th 2022
Three prestigious lectures are featured, including Ehud Assia, MD, from Israel who gave the ESCRS Binkhorst Lecture; Richard Packard, MD, from England who gave the Choyce Lecture to the UKISCRS; and Michael Snyder, of the Cincinnati Eye Institute in Cincinnati, Ohio, USA, who delivered the Kelman Lecture at the 2021 American Academy of Ophthalmology meeting.